Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-National, Multi-Center, DB, Placebo-Controlled, Parallel Group, Fixed Dose Efficacy & Safety Study of SR58611A 350 mg Twice Daily vs. Placebo in Adults With Major Depressive Disorder on Concomitant Treatment With Escitalopram 10mg/d

NCT00432614 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00432614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00432614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-National, Multi-Center, DB, Placebo-Controlled, Parallel Group, Fixed Dose Efficacy & Safety Study of SR58611A 350 mg Twice Daily vs. Placebo in Adults With Major Depressive Disorder on Concomitant Treatment With Escitalopram 10mg/d
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2007
Completion date
February 29, 2008
Enrollment
510 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder